Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool

Osteoporosis International

Volumn 26, Issue 11, 2015, Pages 2573-2578

  Javaid, M K ^a   Kyer, C ^b   Mitchell, P J ^c,d   Chana, J ^e   Moss, C ^f   Edwards, M H ^f   McLellan, A R ^g   Stenmark, J ^b   Pierroz, D D ^b   Schneider, M C ^b   Kanis, J A ^h   Akesson, K ⁱ   Cooper, C ^a,f  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b International Osteoporosis Foundation Switzerland   (Switzerland)

^c Synthesis Medical NZ Ltd   (New Zealand)

^d UNIVERSITY OF NOTRE DAME   (Australia)

^e STOKE MANDEVILLE HOSPITAL   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g WESTERN INFIRMARY   (United Kingdom)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁱ LUND UNIVERSITY   (Sweden)

Author keywords

Adherence; Best Practice Framework; Falls prevention; Fracture Liaison Service; Hip fracture; Osteoporosis; Secondary fracture prevention; Vertebral fracture

Indexed keywords

ARTICLE; BEST PRACTICE FRAMEWORK; CLINICAL EFFECTIVENESS; FRAGILITY FRACTURE; HIP FRACTURE; HOSPITAL; HUMAN; MEDICAL STAFF; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; SPINE FRACTURE; STANDARDIZATION; BENCHMARKING; CLINICAL TRIAL; HEALTH CARE SURVEY; HIP FRACTURES; INTEGRATED HEALTH CARE SYSTEM; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; OSTEOPOROTIC FRACTURES; PRACTICE GUIDELINE; SECONDARY PREVENTION; SPINAL FRACTURES; STANDARDS;

BENCHMARKING; DELIVERY OF HEALTH CARE, INTEGRATED; HEALTH CARE SURVEYS; HIP FRACTURES; HUMANS; OSTEOPOROTIC FRACTURES; PRACTICE GUIDELINES AS TOPIC; SECONDARY PREVENTION; SPINAL FRACTURES;

EID: 84944353441     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-015-3192-0     Document Type: Article

References (27)

1. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733
2. Hernlund E (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1–2):136
3. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359(9319):1761–1767
4. Akesson K, Mitchell PJ (2012) Capture the fracture a global campaign to break the fragility fracture cycle. World Osteoporosis Day Report 2012 [Report] 2012; Available from: http://www.iofbonehealth.org/reports
5. Marsh D et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22(7):2051–2065
6. Eisman JA et al (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27(10):2039–2046
7. Ganda K et al (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24(2):393–406
8. Sale JE et al (2011) Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 22(7):2067–2082
9. Kanis JA et al (2013) SCOPE: a scorecard for osteoporosis in Europe. Arch Osteoporos 8(1–2):144
10. Mithal A, Ebeling P, Kyer C (2013) The Asia-Pacific Regional Audit: epidemiology, costs & burden of osteoporosis in 2013. 2013; Report]. Available from: http://www.iofbonehealth.org/regional-audits
11. Canada O (2014) Quality standards for fracture liaison services in Canada
12. Zealand ON (2014) Fracture liaison services resource pack
13. Adams J et al (2011) Vertebral fracture teaching program
14. Lindley RI (2014) Hip fracture: the case for a funded national registry. Med J Aust 201(7):368–369
15. Thorngren KG (2008) National registration of hip fractures. Acta Orthop 79(5):580–582
16. Heikkinen T et al (2005) Evaluation of 238 consecutive patients with the extended data set of the Standardised Audit for Hip Fractures in Europe (SAHFE). Disabil Rehabil 27(18–19):1107–1115
17. Currie CT, Hutchison JD (2005) Audit, guidelines and standards: clinical governance for hip fracture care in Scotland. Disabil Rehabil 27(18–19):1099–1105
18. Fadda V et al (2014) Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference. J Endocrinol Invest
19. Chang KH et al (2014) Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis. Age (Dordr) 36(2):967–975
20. Knopp-Sihota JA et al (2014) Dementia diagnosis and osteoporosis treatment propensity: a population-based nested case-control study. Geriatr Gerontol Int 14(1):121–129
21. Gleason LJ et al (2012) Diagnosis and treatment of osteoporosis in high-risk patients prior to hip fracture. Geriatr Orthop Surg Rehabil 3(2):79–83
22. Burch J et al (2014) Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups. Health Technol Assess 18(11):1–180
23. Vasikaran S et al (2011) International osteoporosis foundation and international federation of clinical chemistry and laboratory medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med 49(8):1271–1274
24. Bell KJ et al (2009) Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ 338:b2266
25. Hiligsmann M et al (2013) Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group. Osteoporos Int 24(12):2907–2918
26. White HJ et al (2010) A systematic review assessing the effectiveness of interventions to improve persistence with anti-resorptive therapy in women at high risk of clinical fracture. Fam Pract 27(6):593–603
27. Rietbrock S, Olson M, van Staa TP (2009) The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates. QJM 102(1):35–42